Investigating checkpoint inhibitor-induced gastrointestinal disease: comparisons with idiopathic ulcerative colitis and health

In the last decade, immunotherapy with anti-PD1 and anti-CTLA4 drugs has revolutionized the treatment of metastatic cancer. A significant proportion of patients given these checkpoint inhibitors develop off-target inflammation in the colon (checkpoint inhibitor-induced colitis, CC). Ulcerative colit...

Descripción completa

Detalles Bibliográficos
Autor principal: Gupta, T
Otros Autores: Simmons, A
Formato: Tesis
Lenguaje:English
Publicado: 2022
Materias: